Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey
BMC Cancer, 05/11/2012Kodama Y et al.
The proportion of CML patients who sensed a financial burden increased between 2000 and 2008. During this period, their annual incomes fell by 13,000 USD, although their medical expenses did not change. Financial support for patients being treated with expensive drugs remains a major problem in Japan.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.